Weight regain after discontinuing GLP-1 medications is real and documented the STEP 4 trial showed meaningful regain after stopping semaglutide
SURPASS-1 shows that tirzepatide alone, at all doses, was superior to placebo and revealed a dose-dependent reduction of HbA1c by up to 2.07% (p 10% weight loss can be disease modifying and may even lead to disease remission [38]
Common GLP-1 Side Effects The most common side effects when taking GLP-1 medications are gastrointestinal problems, such as nausea, vomiting, diarrhea, constipation, abdominal pain, and bloating
A 30-day supply of oral berberine capsules (1,000 mg/day) costs $10 to $15
Understanding the whole patient prior to receiving transplant and cellular therapy: Real-world data on patients financial toxicity prior to receiving treatment Miranda Kapfhammer 1 , Rachel Cusatis 1 , Deborah Mattila 2 , Sarah Smith 2 1 Medical College of Wisconsin, Milwaukee, USA, 2 National Marrow Donor Program (NMDP), Minneapolis, USA Aims Cellular therapy (CT) recipients are at high risk for financial toxicity (FT) given the frequent need for temporary re-location, loss of income for patients and caregivers in addition to the expected medical expenses of cancer care
An elevated resting heart rate can increase long-term cardiovascular risk, and regulators need robust data confirming that the metabolic benefits outweigh this potential downside